NCT05142358

Brief Summary

Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable lung-cancer

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

October 19, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2026

Completed
Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

3.3 years

First QC Date

October 4, 2021

Last Update Submit

January 29, 2026

Conditions

Keywords

stereotactic body radiation therapycontinuous positive airway pressureCPAPradiationcancerlungDeep inspiratory breath hold (DIBH)

Outcome Measures

Primary Outcomes (3)

  • Dosimetry comparison CPAP and free breathing.

    The primary objective will be to assess changes in lung dosimetry V5 on the affected side when using CPAP compared to free breathing will be measured in percentages.

    At the time of Scan, " Day 1"

  • Dosimetry comparison CPAP and free breathing.

    The primary objective will be to assess changes in lung dosimetry V20 on the affected side when using CPAP compared to free-breathing will be measured in percentages.

    At the time of Scan, " Day 1"

  • Dosimetry comparison CPAP and free breathing.

    The primary objective will be to assess changes in lung dosimetry mean lung on the affected side when using CPAP compared to free-breathing will be measured in Grays.

    At the time of Scan, " Day 1"

Secondary Outcomes (5)

  • Total Lung dosimetry

    At the time of Scan, " Day 1"

  • Cardiac dosimetry with CPAP as compared to free breathing

    At the time of Scan, " Day 1"

  • Measure breast/chest wall or lung tumor motion as well as organ at risk motion

    At the time of Scan, " Day 1"

  • Treatment time with CPAP treatments

    At the time of Scan, " Day 1"

  • Confirm maintenance of inflation with CPAP using surface guidance

    At the time of Scan, " Day 1"

Study Arms (2)

left-sided breast cancer

ACTIVE COMPARATOR

Participants will come in for their regularly scheduled radiation planning and treatment. Participants will undergo three scans (with and without DIBH (i.e., free-breathing), with CPAP). Participants will also use the CPAP device before the CT scan, for which they will be educated and trained.

Device: Continuous Positive Airway PressureOther: Deep inspiratory breath holdOther: Free Breath

Lung SBRT

ACTIVE COMPARATOR

Participants will come in for their regularly scheduled radiation planning and treatment. Participants will undergo three scans (with and without DIBH (i.e., free-breathing), with CPAP). Participants will also use the CPAP device before the CT scan, for which they will be educated and trained.

Device: Continuous Positive Airway PressureOther: Deep inspiratory breath holdOther: Free Breath

Interventions

Regular breathing

Also known as: Without DIBH
Lung SBRTleft-sided breast cancer

Use of CPAP device at the start of treatment planning.

Also known as: CPAP
Lung SBRTleft-sided breast cancer

Treatment during breath holds leads to longer treatment times for patients and radiation oncology departments

Also known as: DIBH
Lung SBRTleft-sided breast cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with left-sided breast cancers
  • Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation
  • Patients undergoing lung SBRT
  • Primary lung cancers
  • Metastatic lung tumors

You may not qualify if:

  • Patients with right side breast cancer
  • Patients who are unable to tolerate the CPAP device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Lung NeoplasmsUnilateral Breast NeoplasmsNeoplasms

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteLung DiseasesRespiratory Tract DiseasesBreast NeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Sheeh Cherian, MD

    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: All participants will undergo standard of care radiation treatment. One additional CT scan will be performed with the use of a CPAP device to determine effect on dosimetry.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2021

First Posted

December 2, 2021

Study Start

October 19, 2022

Primary Completion

January 28, 2026

Study Completion

January 28, 2026

Last Updated

February 2, 2026

Record last verified: 2026-01

Locations